Martingale Asset Management L P Agios Pharmaceuticals, Inc. Transaction History
Martingale Asset Management L P
- $4.01 Billion
- Q4 2024
A detailed history of Martingale Asset Management L P transactions in Agios Pharmaceuticals, Inc. stock. As of the latest transaction made, Martingale Asset Management L P holds 15,520 shares of AGIO stock, worth $477,395. This represents 0.01% of its overall portfolio holdings.
Number of Shares
15,520
Previous 35,293
56.03%
Holding current value
$477,395
Previous $1.57 Million
67.54%
% of portfolio
0.01%
Previous 0.04%
Shares
10 transactions
Others Institutions Holding AGIO
# of Institutions
243Shares Held
59.9MCall Options Held
270KPut Options Held
332K-
Farallon Capital Management LLC San Francisco, CA5.67MShares$175 Million0.99% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.63MShares$173 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.86MShares$149 Million0.0% of portfolio
-
Bellevue Group Ag Kuesnacht, V83.52MShares$108 Million2.3% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.42MShares$74.5 Million0.01% of portfolio
About AGIOS PHARMACEUTICALS, INC.
- Ticker AGIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 54,818,000
- Market Cap $1.69B
- Description
- Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...